August 27, 2012
A New Jersey federal judge ruled last week that a woman's doctor would have prescribed her a Baxter Healthcare Corp. drug even if a warning label described its clotting risks in more detail, handing drugmakers an important victory in an undeveloped area of law in the pharma-heavy state, attorneys say.